STAT News · Scour

Opinion: Same blood test, different results: Why isn’t this common thyroid screening reliable?

statnews.com·12w

STAT+: As oncologists ponder how to integrate AI-powered cancer tools, products are hitting the market

statnews.com·12w

STAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions

statnews.com·12w

Bayer agrees to $7.25 billion proposed settlement over thousands of Roundup cancer lawsuits

statnews.com·12w

STAT+: A shakeup at HHS, a toast to bipartisanship, and a cheese poof war

statnews.com·12w

STAT+: The health care economy, and a surprising Humira chart

statnews.com·12w

STAT+: Does Medicare’s ACCESS model pay enough?

statnews.com·12w

STAT+: Psilocybin data could be good enough for approval

statnews.com·12w

STAT+: Pharmalittle: We’re reading about China’s homegrown GLP-1 drugs, a puzzling FDA rejection, and more

statnews.com·12w

Checking in on RFK Jr.’s promises, one year later

statnews.com·12w

STAT+: Ocular’s experimental eye drug beats low dose of Regeneron’s Eylea in late-stage trial

statnews.com·12w

STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials

statnews.com·12w

STAT+: In a financial pinch, major health insurers are turning to AI for help

statnews.com·12w

STAT+: As China’s drug industry races ahead, its GLP-1 race is accelerating too

statnews.com·12w

Opinion: When IV opioids are in short supply at the hospital, who gets pain relief?

statnews.com·12w

Opinion: AMA CEO: Deepfake doctors are a threat to public health

statnews.com·12w

STAT+: Medicare Advantage growth dwindles for a second straight year

statnews.com·12w

STAT+: Breakup between Brigham and Dana-Farber is getting messier fast

statnews.com·12w

Opinion: How public health saved the CDC Injury Center

statnews.com·12w

STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods

statnews.com·12w

Log in to enable infinite scrolling